Characteristic | Health control | Non-septic infection | Sepsis | p value |
---|---|---|---|---|
Demographics | ||||
N | 25 | 35 | 34 | |
Age (years) | 63.3 ± 14.67 | 68.6 ± 14.22 | 68.2 ± 13.14 | 0.297 |
Gender, male (%) | 14 | 15 | 20 | 0.374 |
Comorbid conditions N (%) | ||||
Diabetes mellitus | 6 | 10 | 12 | 0.632 |
Cardiac insufficiency | 5 | 15 | 15 | 0.114 |
Chronic obstructive pulmonary disease | 1 | 4 | 3 | 0.594 |
Chronic renal insufficency | 2 | 2 | 3 | 0.879 |
Chronic liver disease | 1 | 2 | 3 | 0.740 |
Malignancy | 3 | 1 | 5 | 0.220 |
Site of infection N (%) | ||||
Respiratory | 10 | 15 | 0.209 | |
Urinary | 9 | 8 | 0.833 | |
Abdominal | 7 | 8 | 0.722 | |
Musculoskeletal, skin and soft tissue | 5 | 5 | 0.950 | |
Bloodstream | 7 | 6 | 0.803 | |
Others | 3 | 1 | 0.317 | |
Organ function indices and inflammatory biomarkers | ||||
APACHE II | 5 (2, 6) | 9 (7, 12)a | 20 (14, 25)a,b | 0.000 |
SOFA | 0 (0, 0) | 2 (1, 3)a | 7 (6, 10)a,b | 0.000 |
WBC (109/L) | 6.7 ± 2.72 | 13.7 ± 4.49a | 14.2 ± 6.77a | 0.000 |
CRP (mg/L) | 2.6 ± 3.14 | 64.2 ± 42.37a | 114.0 ± 78.10a,b | 0.000 |
PCT (µg/L) | 0.16 (0.05, 0.26) | 1.19 (0.12, 8.21)a | 10.10 (3.80, 62.36)a,b | 0.000 |
TNF-α (ng/L) | 24.34 (19.17, 43.09) | 36.98 (25.12, 68.23)a | 67.48 (28.95, 92.29)a,b | 0.000 |
IL-6 (ng/L) | 13.30 (6.90, 35.64) | 43.05 (23.45, 81.90)a | 115.33 (60.78, 246.31)a,b | 0.000 |
TRIM7 mRNA (2−△△Ct) | 8.06 (5.28, 13.38) | 2.86 (1.88, 3.97)a | 1.10 (0.83, 2.00)a,b | 0.000 |